Using quality improvement tools to reduce chronic lung disease.
Clinics in perinatology.
Adrenal Cortex Hormones, Bronchopulmonary Dysplasia, Caffeine, Chronic Disease, Continuous Positive Airway Pressure, Humans, Infant, Newborn, Infant, Premature, Infant, Very Low Birth Weight, Intensive Care Units, Neonatal, Lung Diseases, Phosphodiesterase Inhibitors, Pulmonary Surfactants, Quality Improvement, Respiration, Artificial, Respiratory Distress Syndrome, Newborn
Rates of chronic lung disease (CLD) in very low birthweight infants have not decreased at the same pace as other neonatal morbidities over the past 20 years. Multifactorial causes of CLD make this common morbidity difficult to reduce, although there have been several successful quality improvement (QI) projects in individual neonatal intensive care units. QI projects have become a mainstay of neonatal care over the past decade, with an increasing number of publications devoted to this topic. A specific QI project for CLD must be based on best available evidence in the medical literature, expert recommendations, or based on work by previous QI initiatives.
Picarillo, Alan Peter and Carlo, Waldemar, "Using quality improvement tools to reduce chronic lung disease." (2017). Maine Medical Center. 520.